Use access key #2 to skip to page content.
$73.05 -0.21 (-0.29%)
7/18/2008 4:00 PM

Cephalon, Inc. (CEPH)

CAPS Rating:
*****

An international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat human diseases. Currently its four core therapeutic areas are central nervous system disorders, pain, cancer and addiction.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CEPH

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

163 Outperforms
13 Underperforms
 

All-Stars

69 Outperforms
5 Underperforms
 

Wall Street

12 Outperforms
2 Underperforms
 

Players bullish on CEPH are also bullish on:

Players bearish on CEPH are also bearish on:

Ticker Tags

Mid Cap (670), Biotechnology (293), Drug Manufacturers - Other (105)
Suggest a tag

Cephalon, Inc. At A Glance

Current Price: $73.05
Last Trade Time: 7/18/2008 4:00 PM
Open: $73.02
Previous Close: $73.26
Daily Range: $72.60 - $74.00
52-Week Range: $56.20 - $82.90
Volume: 1,280,213
Market Cap: $4.96B
P/E Ratio: 13.02
Compare Our Special Broker Offers!

Stock Trends

CEPH VS S&P 500 (SPY)

CEPH 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for CEPH

More Headlines...

Top Bull Pitch

Recs

1

Cephalon, Inc. (CEPH)

Avatar bouhassi (64.28) Submitted: 6/10/07 11:12 PM

I had the stock or 5 years will growth slowly

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 16 :   1 2 3 4 Next »

Recs

0

 (CEPH)

Avatar ramram50 (< 20) Submitted: 4/14/08 12:33 PM : Outperform Start Price: $63.20 CEPH Score: 20.97

CHEAP AND TAKEOVER CANDIDATE

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CEPH)

Avatar AcubanFOOL (64.94) Submitted: 12/10/07 11:53 AM : Outperform Start Price: $78.64 CEPH Score: 9.84

86/98 -71.5

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (CEPH)

Avatar bouhassi (64.28) Submitted: 6/10/07 11:12 PM : Outperform Start Price: $82.37 CEPH Score: 5.17

I had the stock or 5 years will growth slowly

Report this Post Replies: 0 | Reply | Permalink

Recs

2

 (CEPH)

Avatar genxer36 (77.15) Submitted: 5/29/07 3:15 AM : Outperform Start Price: $80.01 CEPH Score: 8.34

Their mission is to discover and develop innovative medicine for improving human health, Cephalon specializes in medications to treat and manage neurological diseases, sleep disorders, cancer, pain and addiction.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (CEPH)

Avatar boysheagain (< 20) Submitted: 5/04/07 10:35 AM : Outperform Start Price: $79.87 CEPH Score: 7.91

Because of the products it has to offer and the management it provides.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 16 :   1 2 3 4 Next »

Wall Street

Results 1 - 14 of 14  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBroadpointC 86.61 02/13/08 Outperform NS $62.27+17.31%-7.32%+24.63
TrackSoleil 60.33 01/24/08 Outperform NS $69.43+5.21%-6.27%+11.48
TrackFBR 90.59 12/04/07 Outperform NS $76.01-3.89%-14.05%+10.16
TrackLehmanBros 87.77 11/14/07 Outperform NS $77.56-5.81%-15.22%+9.41
TrackAmTech 76.16 11/06/07 Outperform NS $74.19-1.54%-16.48%+14.94
TrackEdwardOwens 98.95 09/30/07 Outperform NS $73.06-0.01%-17.39%+17.37 Toggle the visibility of 60-Second Pitch and replies
TrackJefferies 89.98 04/02/07 Outperform NS $74.12-1.44%-11.33%+9.89
TrackUBS 96.19 03/29/07 Outperform NS $71.17+2.64%-11.43%+14.07
TrackJPMorgan 93.70 01/16/07 Outperform NS $71.47+2.21%-11.90%+14.11
TrackFirstAlbany 79.52 11/03/06 Outperform NS $69.78+4.69%-8.17%+12.86
TrackJMP < 20 09/28/06 Outperform NS $62.24+17.37%-5.82%+23.19
TrackMatrix 89.88 08/25/06 Underperform NS $57.95+26.06%-2.72%-28.77
TrackJimCramer 82.55 08/09/06 Underperform 3W $63.95+14.23%-1.26%-15.49

Results 1 - 14 of 14  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners